📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: iPierian

1.1 - Company Overview

iPierian Logo

iPierian

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a drug discovery platform leveraging induced pluripotent stem cells to discover and develop therapies for neurodegenerative diseases, including SMA, ALS, and Parkinson's, addressing other major unmet medical needs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to iPierian

Levicept Logo

Levicept

HQ: United Kingdom Website
  • Description: Provider of biological therapies for chronic pain, including LEVI-04 (p75NTR-Fc) for knee osteoarthritis that modulates the neurotrophin pathway to minimize side effects associated with anti-NGF antibodies, and a Phase II randomized, double-blind, placebo-controlled clinical trial assessing its efficacy, safety, and tolerability.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Levicept company profile →
Quadrant Biosciences Logo

Quadrant Biosciences

HQ: United States Website
  • Description: Provider of epigenetic diagnostics focused on early detection of neurological disorders, offering: a virtual pediatric clinic for autism evaluations via telehealth; molecular diagnostics for COVID-19, autism and Parkinson’s; autism assessment workflow software; and wastewater monitoring for SARS-CoV-2 and other pathogens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quadrant Biosciences company profile →
Vect-Horus Logo

Vect-Horus

HQ: France Website
  • Description: Provider of peptide-based vectors and the VECTrans technology platform enabling targeted delivery of therapeutic molecules and imaging agents across biological barriers, including the blood-brain barrier, organs, and tumors, by targeting receptors involved in receptor-mediated transport (RMT). Services include vector discovery/optimization, in vitro/in vivo evaluation, internal pipeline development, and R&D, licensing, and strategic partnerships.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vect-Horus company profile →
Braeburn Logo

Braeburn

HQ: United States Website
  • Description: Provider of opioid use disorder solutions, including BRIXADI, a weekly and monthly injectable medication for moderate to severe OUD, and an Investigator-Initiated Trials program that supports independent research to advance medical and scientific understanding of its products and related therapeutic areas.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Braeburn company profile →
Convelo Therapeutics Logo

Convelo Therapeutics

HQ: United States Website
  • Description: Provider of novel remyelinating therapeutics that regenerate myelin in the central nervous system to restore function, supported by a proprietary screening platform that identifies candidates acting on oligodendrocyte progenitor cells, and a collaboration with Genentech to accelerate discovery and development of medicines for neurological disorders such as multiple sclerosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Convelo Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for iPierian

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to iPierian

2.2 - Growth funds investing in similar companies to iPierian

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for iPierian

4.2 - Public trading comparable groups for iPierian

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to iPierian

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About iPierian

What does iPierian do?

iPierian is a provider of a drug discovery platform leveraging induced pluripotent stem cells to discover and develop therapies for neurodegenerative diseases, including SMA, ALS, and Parkinson's, addressing other major unmet medical needs.

Who are iPierian's competitors?

iPierian's competitors and similar companies include Levicept, Quadrant Biosciences, Vect-Horus, Braeburn, and Convelo Therapeutics.

Where is iPierian headquartered?

iPierian is headquartered in United States.

How many employees does iPierian have?

iPierian has 1,000 employees 🔒.

When was iPierian founded?

iPierian was founded in 2010 🔒.

What sector and industry vertical is iPierian in?

iPierian is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for iPierian

Who are the top strategic acquirers in iPierian's sector and industry

Top strategic M&A buyers and acquirers in iPierian's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for iPierian?

Top strategic M&A buyers groups and sectors for iPierian include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in iPierian's sector and industry vertical

Which are the top PE firms investing in iPierian's sector and industry vertical?

Top PE firms investing in iPierian's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in iPierian's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in iPierian's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in iPierian's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to iPierian include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in iPierian's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for iPierian?

The key public trading comparables and valuation benchmarks for iPierian include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for iPierian for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for iPierian with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in iPierian's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for iPierian with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in iPierian's' sector and industry vertical?

Access recent funding rounds and capital raises in iPierian's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for iPierian